Psilocybin Is Entering State-Regulated Treatment Programs. Has the Science Caught Up?
What psilocybin trials show about depression, safety, and blinding, where Phase 3 data and FDA review stand, and how regulated access differs in Oregon, Colorado, and New Mexico.
What Happens After the Psychedelic Experience
I attended ICPR 2026 in the Netherlands to learn from researchers and clinicians at the forefront of psychedelic science. One takeaway stood out: more people are having psychedelic experiences than ever before, yet many struggle to find a safe place to process them. Here's why I'm now offering psychedelic integration sessions.

